HCW Biologics Inc.
HCWB
Positions held
Your positionsHCWB isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $3.42M | Enterprise value | $8.63M | Trailing P/E | — | Forward P/E | -2.78 |
| PEG | — | Price / book | 0.33 | Beta | 2.42 | Dividend yield | 0.00% |
| Revenue growth | 19.7% | Earnings growth | — | Gross margin | 95.9% | Operating margin | -23.4% |
| Profit margin | -83.0% | ROE | -1.5% | ROA | -13.9% | Debt / equity | 0.88 |
| Current ratio | 0.06 | Free cash flow | -$11.66M | Analyst recommendation | buy | Mean target | $48.00 |
| 52w high | $27.57 | 52w low | $1.50 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.1M | $6.5M | $0.0M | $0.0M | $0.0M | — |
| Op margin | -2324.9% | 49.7% | -10912.3% | -20995.9% | -51325.6% | — |
| Net income | -$5.2M | $3.5M | $0.7M | -$4.6M | -$1.9M | — |
| Gross margin | -69.3% | 99.8% | 20.0% | 20.0% | 20.0% | — |
| Gross profit | -$0.1M | $6.5M | $0.0M | $0.0M | $0.0M | — |
| Operating income | -$3.2M | $3.3M | -$2.9M | -$3.3M | -$3.4M | — |
- Revenue -98% vs prior quarter ($0.1M vs $6.5M).
- Gross margin -69.3% (was 99.8% prior quarter).
- Operating margin compressed to -2325%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.1M | $2.6M | $2.8M | $6.7M | — |
| Op margin | -20757.6% | -1076.4% | -905.0% | -224.3% | — |
| Net income | -$8.0M | -$30.0M | -$25.0M | -$14.9M | — |
| Gross margin | 20.0% | 37.4% | 19.7% | 38.5% | — |
| Gross profit | $0.0M | $1.0M | $0.6M | $2.6M | — |
| Operating income | -$11.3M | -$27.6M | -$25.7M | -$15.1M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-24 · HCW Biologics Announces Pricing of $1.5 Million Private Placement
2026-09-08 · HCW Biologics Signs Akron Biotech Distribution Deal for CAR-T Manufacturing Reagent
2026-09-02 · HCW Biologics Receives US Patent Allowance for HCW9302 in Alopecia Areata
2026-08-14 · HCW Biologics Reports Second Quarter 2026 Business and Clinical Development Highlights and Financial Results
2026-07-29 · HCW Biologics Prices $1.6 Million Private Placement Offering
2026-07-29 · HCW Biologics Inc. Announces Pricing of $1.6 Million Private Placement Offering
Price (daily)
Full chart · RSI · MACD · patterns